{"altmetric_id":12244696,"counts":{"readers":{"mendeley":36,"citeulike":0,"connotea":0},"total":{"posts_count":15},"news":{"unique_users_count":1,"unique_users":["medwirenews"],"posts_count":1},"twitter":{"unique_users_count":9,"unique_users":["antoniombermejo","NeurologyToday","NeuroLlama","AMoosaMD","AmEpilepsySoc","NeurolinxOrg","sidkapooruky","shang3923","AnestesiaF"],"posts_count":10},"facebook":{"unique_users_count":4,"unique_users":["726437480754534","162629307154967","109563799133673","193133835711"],"posts_count":4}},"selected_quotes":["Therapeutic coma for status epilepticus: Differing practices in a prospective multicenter study. #PrecisionMedicine","Drug induced coma for refractory status epilepticus. Practice vary among centers. #epilepsy","Therapeutic coma does not affect outcome but may incr LOS in a large multicenter analysis.","Therapeutic coma for status epilepticus: Differing practices in a prospective multicenter study."],"citation":{"abstract":"Our aim was to analyze and compare the use of therapeutic coma (TC) for refractory status epilepticus (SE) across different centers and its effect on outcome.\nClinical data for all consecutive adults (>16 years) with SE of all etiologies (except postanoxic) admitted to 4 tertiary care centers belonging to Harvard Affiliated Hospitals (HAH) and the Centre Hospitalier Universitaire Vaudois (CHUV) were prospectively collected and analyzed for TC details, mortality, and duration of hospitalization.\nTwo hundred thirty-six SE episodes in the CHUV and 126 in the HAH were identified. Both groups were homogeneous in demographics, comorbidities, SE characteristics, and Status Epilepticus Severity Score (STESS); TC was used in 25.4% of cases in HAH vs 9.75% in CHUV. After adjustment, TC use was associated with younger age, lower Charlson Comorbidity Index, increasing SE severity, refractory SE, and center (odds ratio 11.3 for HAH vs CHUV, 95% confidence interval 2.47-51.7). Mortality was associated with increasing Charlson Comorbidity Index and STESS, etiology, and refractory SE. Length of stay correlated with STESS, etiology, refractory SE, and use of TC (incidence rate ratio 1.6, 95% confidence interval 1.22-2.11).\nUse of TC for SE treatment seems markedly different between centers from the United States and Europe, and did not affect mortality considering the whole cohort. However, TC may increase length of hospital stay and related costs.\nThis study provides Class III evidence that for patients with SE, TC does not significantly affect mortality. The study lacked the precision to exclude an important effect of TC on mortality.","altmetric_jid":"4f6fa5ea3cf058f610005b59","authors":["Vincent Alvarez","Jong Woo Lee","M. Brandon Westover","Frank W. Drislane","Jan Novy","Mohamed Faouzi","Nicola A. Marchi","Barbara A. Dworetzky","Andrea O. Rossetti","Alvarez, Vincent","Lee, Jong Woo","Westover, M Brandon","Drislane, Frank W","Novy, Jan","Faouzi, Mohamed","Marchi, Nicola A","Dworetzky, Barbara A","Rossetti, Andrea O"],"doi":"10.1212\/wnl.0000000000003224","endpage":"1659","first_seen_on":"2016-09-27T17:36:29+00:00","funders":["niehs"],"issns":["1526-632X","0028-3878"],"issue":"16","journal":"Neurology","last_mentioned_on":1494410523,"links":["http:\/\/www.neurology.org\/content\/early\/2016\/09\/23\/WNL.0000000000003224.short","http:\/\/m.neurology.org\/content\/early\/2016\/09\/23\/WNL.0000000000003224.short","http:\/\/www.neurology.org\/content\/early\/2016\/09\/23\/WNL.0000000000003224.abstract?ct","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27664985","http:\/\/neurology.org\/lookup\/doi\/10.1212\/WNL.0000000000003224","http:\/\/www.neurology.org\/content\/early\/2016\/09\/23\/WNL.0000000000003224.abstract","http:\/\/www.neurology.org\/content\/87\/16\/1650.short?utm_content=buffer4d519&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer","http:\/\/www.neurology.org\/content\/87\/16\/1650.short?utm_content=buffercb392&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27664985?dopt=Abstract"],"pdf_url":"http:\/\/www.neurology.org\/content\/early\/2016\/09\/23\/WNL.0000000000003224.full.pdf","pmid":"27664985","pubdate":"2016-09-24T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Neurosciences","scheme":"era"},{"name":"Cognitive Science","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"10.1212\/WNL.0000000000003224","subjects":["neurology"],"title":"Therapeutic coma for status epilepticus","type":"article","uri":"http:\/\/www.neurology.org\/lookup\/doi\/10.1212\/WNL.0000000000003224","volume":"87","mendeley_url":"http:\/\/www.mendeley.com\/research\/therapeutic-coma-status-epilepticus-differing-practices-prospective-multicenter-study"},"altmetric_score":{"score":14.45,"score_history":{"1y":14.45,"6m":0.25,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":14.45},"context_for_score":{"all":{"total_number_of_other_articles":8394942,"mean":7.0701406373119,"rank":603855,"this_scored_higher_than_pct":92,"this_scored_higher_than":7789937,"rank_type":"exact","sample_size":8394942,"percentile":92},"similar_age_3m":{"total_number_of_other_articles":252437,"mean":12.713032657782,"rank":29799,"this_scored_higher_than_pct":88,"this_scored_higher_than":222569,"rank_type":"exact","sample_size":252437,"percentile":88},"this_journal":{"total_number_of_other_articles":9921,"mean":13.994042943548,"rank":1544,"this_scored_higher_than_pct":84,"this_scored_higher_than":8372,"rank_type":"exact","sample_size":9921,"percentile":84},"similar_age_this_journal_3m":{"total_number_of_other_articles":324,"mean":43.736037151703,"rank":99,"this_scored_higher_than_pct":69,"this_scored_higher_than":225,"rank_type":"exact","sample_size":324,"percentile":69}}},"demographics":{"poster_types":{"member_of_the_public":7,"practitioner":1,"science_communicator":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":1,"Members of the public":7,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Professor > Associate Professor":3,"Librarian":1,"Researcher":13,"Student  > Ph. D. Student":1,"Student  > Postgraduate":5,"Other":6,"Lecturer":1,"Student  > Doctoral Student":1,"Student  > Master":5},"by_discipline":{"Medicine and Dentistry":25,"Neuroscience":4,"Agricultural and Biological Sciences":3,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":3}}},"geo":{"twitter":{"ES":1,"US":5},"mendeley":{"US":3,"CH":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/antoniombermejo\/statuses\/783369543523655680","license":"gnip","citation_ids":[12244696],"posted_on":"2016-10-04T18:13:48+00:00","author":{"name":"Neuroped Hosp La Paz","image":"https:\/\/pbs.twimg.com\/profile_images\/911251806281457666\/pa7sOYB7_normal.jpg","description":"Servicio de Neuropediatr\u00eda. Hospital Infantil La Paz. Universidad Aut\u00f3noma. Madrid. Espa\u00f1a","id_on_source":"antoniombermejo","tweeter_id":"2571414216","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":656},"tweet_id":"783369543523655680"},{"url":"http:\/\/twitter.com\/NeurologyToday\/statuses\/781146501170900993","license":"gnip","citation_ids":[12244696],"posted_on":"2016-09-28T15:00:13+00:00","author":{"name":"Neurology Today","url":"http:\/\/www.neurotodayonline.com","image":"https:\/\/pbs.twimg.com\/profile_images\/474220858295078914\/vUs3O0B__normal.png","description":"The official news source of the American Academy of Neurology, published by Wolters Kluwer.","id_on_source":"NeurologyToday","tweeter_id":"21938868","geo":{"lt":44.97997,"ln":-93.26384,"country":"US"},"followers":31377},"tweet_id":"781146501170900993"},{"url":"http:\/\/twitter.com\/NeuroLlama\/statuses\/781147463436668929","license":"gnip","citation_ids":[12244696],"posted_on":"2016-09-28T15:04:02+00:00","author":{"name":"NeuroLlama","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000212380033\/67c0d9f1df4328803d6c4eb7ada5c7e3_normal.jpeg","description":"Brandon Foreman MD. Neurointensivist, neurophysiologist, and Peruvian Fancy\u2122 Llama. #neurocritical #ICU #FOAMed. Alter Ego\/Slacktivism: @thetiltedllama","id_on_source":"NeuroLlama","tweeter_id":"1631903526","geo":{"lt":39.162,"ln":-84.45689,"country":"US"},"followers":195},"tweet_id":"781147463436668929"},{"url":"http:\/\/twitter.com\/AMoosaMD\/statuses\/784590155604713477","license":"public","citation_ids":[12244696],"posted_on":"2016-10-08T03:04:04+00:00","author":{"name":"Ahsan Moosa Naduvil","url":"http:\/\/my.clevelandclinic.org\/staff_directory\/staff_display?DoctorID=18141","image":"https:\/\/pbs.twimg.com\/profile_images\/709043086085758976\/Hehm60AV_normal.jpg","description":"Pediatric Epilepsy Expert I Cleveland Clinic Epilepsy Center I Tweets my Own. #RefractoryEpilepsy #EpilepsySurgery #Quality #PatientSafety","id_on_source":"AMoosaMD","tweeter_id":"1059652796","geo":{"lt":41.4995,"ln":-81.69541,"country":"US"},"followers":270},"tweet_id":"784590155604713477"},{"url":"http:\/\/twitter.com\/AmEpilepsySoc\/statuses\/842096337592156161","license":"gnip","citation_ids":[12244696],"posted_on":"2017-03-15T19:33:06+00:00","author":{"name":"Am. Epilepsy Society","url":"http:\/\/www.aesnet.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/884783655834472448\/9vaO_3n-_normal.jpg","description":"Official account for American Epilepsy Society. We support research and education for professionals committed to a world without epilepsy. RTs \u2260 endorsements.","id_on_source":"AmEpilepsySoc","tweeter_id":"479625194","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":3087},"tweet_id":"842096337592156161"},{"url":"http:\/\/twitter.com\/antoniombermejo\/statuses\/842098892183343104","license":"gnip","citation_ids":[12244696],"posted_on":"2017-03-15T19:43:15+00:00","author":{"name":"Neuroped Hosp La Paz","image":"https:\/\/pbs.twimg.com\/profile_images\/911251806281457666\/pa7sOYB7_normal.jpg","description":"Servicio de Neuropediatr\u00eda. Hospital Infantil La Paz. Universidad Aut\u00f3noma. Madrid. Espa\u00f1a","id_on_source":"antoniombermejo","tweeter_id":"2571414216","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":656},"tweet_id":"842098892183343104"},{"url":"http:\/\/twitter.com\/NeurolinxOrg\/statuses\/842117193273860096","license":"gnip","rt":["AmEpilepsySoc"],"citation_ids":[12244696],"posted_on":"2017-03-15T20:55:59+00:00","author":{"name":"Neurolinx","url":"https:\/\/neurolinx.org","image":"https:\/\/pbs.twimg.com\/profile_images\/3779898544\/d5b6293ed288d44f1f8420d96a0b54f9_normal.png","description":"A non-profit neuroscience institute dedicated to Liberating Discovery (R) through open science, collaboration and innovation. Most tweets by Jay Coggan.","id_on_source":"NeurolinxOrg","tweeter_id":"1497484554","geo":{"lt":null,"ln":null},"followers":986},"tweet_id":"842117193273860096"},{"url":"http:\/\/twitter.com\/sidkapooruky\/statuses\/842186148298543104","license":"gnip","rt":["AmEpilepsySoc"],"citation_ids":[12244696],"posted_on":"2017-03-16T01:29:59+00:00","author":{"name":"Siddharth Kapoor","url":"http:\/\/ukneurology.com\/kapoor.html","image":"https:\/\/pbs.twimg.com\/profile_images\/478689530254745600\/-7Uo2btr_normal.jpeg","description":"Neurologist, Epileptologist, Headache Specialist, Patient Advocate, Clinician, Educator, Program Director at Univ of Kentucky","id_on_source":"sidkapooruky","tweeter_id":"764157571","geo":{"lt":37.98869,"ln":-84.47772,"country":"US"},"followers":242},"tweet_id":"842186148298543104"},{"url":"http:\/\/twitter.com\/shang3923\/statuses\/842190754760036353","license":"gnip","rt":["AmEpilepsySoc"],"citation_ids":[12244696],"posted_on":"2017-03-16T01:48:17+00:00","author":{"name":"DESiree May","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000372656824\/7c45fe9fcce81dec1b843f94537045a1_normal.jpeg","id_on_source":"shang3923","tweeter_id":"1678443565","geo":{"lt":null,"ln":null},"followers":54},"tweet_id":"842190754760036353"},{"url":"http:\/\/twitter.com\/AnestesiaF\/statuses\/862246345847001088","license":"gnip","citation_ids":[12244696],"posted_on":"2017-05-10T10:02:03+00:00","author":{"name":"Anestesia-Fabumed","url":"http:\/\/www.fabumed.net\/","image":"https:\/\/pbs.twimg.com\/profile_images\/513933046764957696\/2ZhExTfY_normal.png","description":"Anestesia. Compartir, revisar y fomentar la realizaci\u00f3n de referencias de la Literatura M\u00e9dica Latinoamericana y a sus Autores.","id_on_source":"AnestesiaF","tweeter_id":"380571588","geo":{"lt":null,"ln":null},"followers":1638},"tweet_id":"862246345847001088"}],"news":[{"title":"Reserve urged when using therapeutic coma in SE treatment","url":"http:\/\/ct.moreover.com\/?a=28098145050&p=1pl&v=1&x=zZuPccLW3kxAcLzFWOedjw","license":"public","citation_ids":[12244696,12244698],"posted_on":"2016-09-27T17:33:07+00:00","summary":"medwireNews: Therapeutic coma should be reserved for severe refractory convulsive status epilepticus (SE) after adequate and early dosing of first- and second-line drugs in line with current recommendations, say researchers.","author":{"name":"medwireNews","url":"http:\/\/www.medwirenews.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/070\/normal\/image.png?1369859687"}}],"facebook":[{"title":"Therapeutic coma for status epilepticus","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1303241143074162&id=726437480754534","license":"public","citation_ids":[12244696],"posted_on":"2016-09-27T16:30:00+00:00","summary":"coma or no coma for refractory SE?\n\nhttp:\/\/www.neurology.org\/content\/early\/2016\/09\/23\/WNL.0000000000003224.abstract?ct","author":{"name":"Neurology Times","url":"https:\/\/www.facebook.com\/726437480754534","facebook_wall_name":"Neurology Times","image":"https:\/\/graph.facebook.com\/726437480754534\/picture","id_on_source":"726437480754534"}},{"title":"Therapeutic coma for status epilepticus","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1175002725917615&id=162629307154967","license":"public","citation_ids":[12244696],"posted_on":"2016-11-07T22:00:00+00:00","summary":"How important is therapeutic coma for treating refractory status epilepticus?\n\nHeavy duty sedation may be less important than you think. This comparison between European & American centers is worth a read.","author":{"name":"Neurohospitalist Society","url":"https:\/\/www.facebook.com\/162629307154967","facebook_wall_name":"Neurohospitalist Society","image":"https:\/\/graph.facebook.com\/162629307154967\/picture","id_on_source":"162629307154967"}},{"title":"Therapeutic coma for status epilepticus","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1263978327025542&id=109563799133673","license":"public","citation_ids":[12244696],"posted_on":"2017-03-06T15:08:06+00:00","summary":"Skip to main page content","author":{"name":"American Epilepsy Society","url":"https:\/\/www.facebook.com\/109563799133673","facebook_wall_name":"American Epilepsy Society","image":"https:\/\/graph.facebook.com\/109563799133673\/picture","id_on_source":"109563799133673"}},{"url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10154623967270712&id=193133835711","license":"public","citation_ids":[12244696],"posted_on":"2016-09-28T15:00:32+00:00","summary":"When researchers compared the use of therapeutic coma (TC) for status epilepticus between United States hospitals and a hospital in Switzerland, they found TC was more commonly used in the US. However, they found increased use did not significantly affect","author":{"name":"Neurology Today","url":"https:\/\/www.facebook.com\/193133835711","facebook_wall_name":"Neurology Today","image":"https:\/\/graph.facebook.com\/193133835711\/picture","id_on_source":"193133835711"}}]}}